These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6366560

  • 1. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, Grassi C, Limido D, Pasquali S, Volpini T.
    N Engl J Med; 1984 Apr 12; 310(15):946-50. PubMed ID: 6366560
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 3. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F.
    Proc Eur Dial Transplant Assoc; 1983 Jan 05; 19():717-23. PubMed ID: 6348763
    [Abstract] [Full Text] [Related]

  • 4. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B.
    N Engl J Med; 1992 Aug 27; 327(9):599-603. PubMed ID: 1640953
    [Abstract] [Full Text] [Related]

  • 5. Treatment of membranous lupus nephritis.
    Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C.
    Am J Kidney Dis; 1998 Apr 27; 31(4):681-6. PubMed ID: 9531186
    [Abstract] [Full Text] [Related]

  • 6. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb 27; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of efficacy of methylprednisolone, prednisolone and chlorambucil in idiopathic glomerulonephritis.
    Nand N, Das R, Jaswal TS.
    J Indian Med Assoc; 1997 Jun 27; 95(6):163-5, 174. PubMed ID: 9420390
    [Abstract] [Full Text] [Related]

  • 8. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
    Polenakovik MH, Grcevska L.
    Am J Kidney Dis; 1999 Nov 27; 34(5):911-7. PubMed ID: 10561149
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 Nov 27; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 10. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M, Grcevska L, Dzikova S.
    Prilozi; 2006 Dec 27; 27(2):5-12. PubMed ID: 17211287
    [Abstract] [Full Text] [Related]

  • 11. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, Minari M, Scalia A, Pedrini L, Pisano G, Grassi C, Farina M, Bellazzi R.
    J Am Soc Nephrol; 1998 Mar 27; 9(3):444-50. PubMed ID: 9513907
    [Abstract] [Full Text] [Related]

  • 12. Idiopathic membranous nephropathy in the elderly.
    Passerini P, Como G, Viganò E, Melis P, Pozzi C, Altieri P, Ponticelli C.
    Nephrol Dial Transplant; 1993 Mar 27; 8(12):1321-5. PubMed ID: 8159299
    [Abstract] [Full Text] [Related]

  • 13. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
    Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S.
    N Engl J Med; 1989 Jan 26; 320(4):210-5. PubMed ID: 2643046
    [Abstract] [Full Text] [Related]

  • 14. [Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results].
    Imbasciati E, Cagnoli L, Case N, Pasquali S, Di Filippo G, Limido D, Cornalba L, Volpini T, Pozzi C, Zuccelli P, Ponticelli C.
    Minerva Nefrol; 1980 Jan 26; 27(4):571-5. PubMed ID: 7019771
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and morphologic evolution of idiopathic membranous nephropathy.
    Zucchelli P, Cagnoli L, Pasquali S, Casanova S, Donini U.
    Clin Nephrol; 1986 Jun 26; 25(6):282-8. PubMed ID: 3524923
    [Abstract] [Full Text] [Related]

  • 16. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May 26; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 17. Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure.
    Warwick GL, Geddes CG, Boulton-Jones JM.
    Q J Med; 1994 Apr 26; 87(4):223-9. PubMed ID: 8208913
    [Abstract] [Full Text] [Related]

  • 18. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C.
    Kidney Int; 1995 Nov 26; 48(5):1600-4. PubMed ID: 8544420
    [Abstract] [Full Text] [Related]

  • 19. The advantages of immunosuppressive therapy in renal disease.
    Zucchelli P.
    Ann Med Interne (Paris); 1988 Nov 26; 139(2):108-11. PubMed ID: 3293499
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May 26; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.